`Britain’s GW Pharmaceuticals Plc said Tuesday it plans to start human trials of an experimental treatment for obesity derived from cannabis. [..]
“The cannabis plant has 70 different cannabinoids in it, and each has a different effect on the body,” GW Managing Director Justin Gover told Reuters.
“Some can stimulate your appetite, and some in the same plant can suppress your appetite. It is amazing both scientifically and commercially,” he said in a telephone interview.’